Evidence map›Paper›PMID 37024776›Full record

ArticleBMC infectious diseases2023

Coexistence of COVID-19, Pseudomonas, and thoracic actinomycosis in a cystic bronchiectasis case.

Emine Afsin, Furkan Kucuk, Hüsna Ozcelik, Muhammed Yavuz Haktanır

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BMC infectious diseases, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Emine AfsinDepartment of Chest Diseases, Abant Izzet Baysal University Hospital, Golkoy, Bolu, 14200, Turkey. emineafsin@yahoo.com.ORCID http://orcid.org/0000-0002-2450-6378
Furkan KucukDepartment of Chest Diseases, Abant Izzet Baysal University Hospital, Golkoy, Bolu, 14200, Turkey.
Hüsna OzcelikDepartment of Pathology, Abant Izzet Baysal University Hospital, Golkoy, Bolu, 14200, Turkey.
Muhammed Yavuz HaktanırDepartment of Thoracic Surgery, Abant Izzet Baysal University Hospital, Golkoy, Bolu, 14200, Turkey.
Bolu Abant İzzet Baysal University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Actinomycosis often leads to cervicofacial infections, but thoracic involvement may also occur. However, the development of empyema is rare. While being followed up with the diagnosis of asthma and bronchiectasis, our case was hospitalized for infected bronchiectasis. As empyema developed in the follow-up, the pleural effusion was drained by tube thoracostomy. Actinomycosis was diagnosed through pleural effusion cytology. Growth of Pseudomonas aeruginosa was observed in sputum culture, and SARS-CoV2 RT-PCR was also positive in nasopharyngeal sampling. Polymicrobial agents can often be detected in actinomycosis. Actinomycosis cases have also been reported in the post-COVID period. Our case is presented since it would be the first in the literature regarding the coexistence of COVID-19, Pseudomonas, and thoracic Actinomycosis (empyema).

Indexed as

ActinomycosisBronchiectasisCOVID-19EmpyemaLung DiseasesPleural EffusionPseudomonas InfectionsHumansPseudomonasRNA, ViralSARS-CoV-2RNA, ViralCOVID-19Cystic bronchiectasisPseudomonas aeruginosaThoracic Actinomycosis

Identifiers

PMID37024776
PMCPMC10078035
OpenAlexW4362669947

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.